title: HAART for HIV-1 infection: zeroing in on when to start: comment on "Timing of HAART initiation and clinical outcomes in human immunodeficiency virus type 1 seroconverters".
authors.affiliation: Section of Retroviral Therapeutics, Brigham and Women's Hospital, and Harvard Medical School, 65 Landsdowne St, Room 449, Cambridge, MA 02139, USA. dkuritzkes@partners.org
authors.forename: Daniel R
authors.initials: DR
authors.lastname: Kuritzkes
mesh_terms: D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006679:HIV Seropositivity / Q000188:drug therapy*; D015497:HIV-1; D006801:Humans; D008297:Male